Use of fusion images of I-131 metaiodobenzylguanidine, SPECT, and magnetic resonance studies to identify a malignant pheochromocytoma
Use of fusion images of I-131 metaiodobenzylguanidine, SPECT, and magnetic resonance studies to identify a malignant pheochromocytoma
复制标题
DOI：
10.1097/00003072-200006000-00010
复制
发表时间：
2000-06-01
影响因子：
10.6
通讯作者：
Kanazawa, K
中科院分区：
文献类型：
--
作者：
Fujita, A;Hyodoh, H;Kanazawa, K
嗜铬细胞瘤是一种染色质肿瘤，其中10%为肾上腺外肿瘤，10%为恶性肿瘤，I-131 metaiodobenzylguanidine （MIBG）显像在鉴别这些肿瘤和研究转移性病变方面具有重要作用。作者描述了一位36岁的女性，她接受了恶性左肾上腺嗜铬细胞瘤切除术，她被认为在肝脏和主动脉旁淋巴结有转移。获得I-131 MIBG SPECT和磁共振研究的融合图像，以正确识别转移灶。这些融合图像对后续手术有很大帮助。
Pheochromocytoma is a chromaffin tumor in which 10% are extra-adrenal and 10% are malignant, I-131 metaiodobenzylguanidine (MIBG) scintigraphy has an important role in the identification of these tumors and investigation of metastatic lesions. The authors describe a 36-year-old woman who underwent resection of a malignant left adrenal pheochromocytoma who was thought to have metastases in the liver and para-aortic lymph nodes. Fusion images of I-131 MIBG SPECT and magnetic resonance studies were obtained to properly identify the metastatic lesions. These fusion images helped greatly in subsequent surgery.